DOXORUBICIN EXTRA

Serial Number 74410838
606

Registration Progress

Application Filed
Jul 8, 1993
Under Examination
May 30, 1995
Approved for Publication
Jul 22, 1994
Published for Opposition
Aug 23, 1994
Registered

Trademark Image

DOXORUBICIN EXTRA

Basic Information

Serial Number
74410838
Filing Date
July 8, 1993
Published for Opposition
August 23, 1994
Abandonment Date
May 31, 1998
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 31, 1998

Rights Holder

SUPERGENERICS, INC.

03
Address
6400 Hollis Street
Suite 8
Emeryville, CA 94608

Ownership History

SUPERGENERICS, INC.

Original Applicant
03
Emeryville, CA

SUPERGENERICS, INC.

Owner at Publication
03
Emeryville, CA

Legal Representation

Attorney
Kenneth E. Krosin

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description Documents
May 31, 1998 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 13, 1998 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 28, 1997 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 24, 1997 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 30, 1997 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 16, 1997 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 29, 1996 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 12, 1996 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 15, 1996 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 16, 1996 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 14, 1995 EXT1 S SOU EXTENSION 1 FILED Loading...
May 30, 1995 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 21, 1994 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Aug 23, 1994 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 22, 1994 NPUB O NOTICE OF PUBLICATION Loading...
May 20, 1994 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 17, 1994 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Nov 15, 1993 CNRT F NON-FINAL ACTION MAILED Loading...
Oct 29, 1993 DOCK D ASSIGNED TO EXAMINER Loading...

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"DOXORUBICIN"